Telo Genomics (TSXV:TELO) YoY EBITDA Growth : -9.09% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Telo Genomics's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -9.09%.

Telo Genomics's EBITDA per Share for the three months ended in Dec. 2023 was C$-0.01.

Telo Genomics YoY EBITDA Growth Historical Data

The historical data trend for Telo Genomics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics YoY EBITDA Growth Chart

Telo Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

YoY EBITDA Growth

Get a 7-Day Free Trial

80.53

47.95

34.21

-40.00

-31.43

Telo Genomics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-37.50	-50.00	-27.27	10.00	-9.09

Telo Genomics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Telo Genomics's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (A: Jun. 2023 )
=	(EBITDA per Share (A: Jun. 2023 )	-	EBITDA per Share (A: Jun. 2022 ))	/	\| EBITDA per Share (A: Jun. 2022 ) \|
=	(-0.046	-	-0.035)	/	\| -0.035 \|
=	-31.43 %

Telo Genomics's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.012	-	-0.011)	/	\| -0.011 \|
=	-9.09 %

Telo Genomics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Telo Genomics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Telo Genomics (TSXV:TELO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

TDSGF:USA 3D0A:Germany

Address

101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7

Website

https://www.telodx.com

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (TSXV:TELO) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024